https://investorsmedia.mesoblast.com/static-files/e14d0449-ba07-4755-815d-99adf40ddc17
There have been a number of scenarios of Real World Evidence (RWE) that IMO support Mesoblast's decision to plan to run and additional COVID-19 ARDS Phase 3 trial using Remestemcel-L ... I thought we could use this thread to post them as we come across them ? Use the thread or don't use it; entirely up to you
An exponential increase in case numbers like this - 1,044,970 new cases in one day and USA hospitalisations up by 41% in two weeks would IMO support SI's reasons for undertaking an additional COVID-19 ARDS Phase 3 trial in the USA using our Remestemcel-L treatment.
https://www.nbcnews.com/news/us-new...-covid-cases-spread-omicron-variant-rcna10866
U.S. reaches 1 million daily Covid cases in spread of omicron variant
RWE for 2nd MSB COVID-19 ARDS P3 Trial
-
- There are more pages in this discussion • 905 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |